Ordaos, Inc.
Biotechnology company · New York, United States
Ordaos, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2019. It has reported private securities offerings to the US SEC, most recently $337,705 sold in a notice filed in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Ordaos at a glance
Typebiotechnology company
HeadquartersNew York, United States
Earliest incorporation on record2019
SEC CIK1933700
What does Ordaos do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $337,705 sold (2025).
Frequently asked questions about Ordaos
Where is Ordaos headquartered?
Ordaos, Inc. is headquartered in New York, United States.
What does Ordaos do?
Ordaos, Inc. is a biotechnology company.
When was Ordaos founded?
The earliest incorporation on record for Ordaos, Inc. is in 2019, according to public company registers.
Similar companies
- Lexeo Therapeutics, Inc.New York City, New York, United States
- MiNK Therapeutics, Inc.New York City, New York, United States
- IN8BIO, Inc.New York City, New York, United States
- Anavex Life Sciences Corp.New York City, New York, United States
- Brainstorm Cell Therapeutics Inc.New York City, New York, United States
- Bioincept LLCNew York City, New York, United States
- Protara Therapeutics, Inc.New York City, New York, United States
- Ancilia Biosciences, Inc.New York City, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences